Michael Garrett

Michael Garrett

Michael Garrett

CEO & Co-Founder - Flamingo Therapeutics

Mike has more than 25 years’ experience in the biotech industry in positions of increasing responsibility.  Prior to co-founding Flamingo, he was a Partner with TCG, a life science consulting group in RTP, North Carolina. Prior to this he was Vice President of Corporate Development at Scynexis, Inc. and a member of the team that executed the company’s IPO.  Mike was Global Vice President, Ventures & Business Development for BTG plc, with responsibility for the company’s investment portfolio. Prior to this he worked in the corporate venture group of Aventis (Paris) and in their business development group. Earlier in his career he was a patent attorney in the Rhone-Poulenc Intellectual Property department, based in France and the UK.

 

Mike is a British and European Patent Attorney, holds an Honors degree in Chemistry from Southampton University, UK and an Executive Certificate in General Management from the Cedep INSEAD business school, France.

Join us in person on 19 May

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners